Capecitabine trials for Metastatic Colorectal Cancer

All Capecitabine trials · All Metastatic Colorectal Cancer trials

Phase breakdown

Recruiting trials studying Capecitabine for Metastatic Colorectal Cancer

• A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
  NCT06493760 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer
  NCT05093907 · Phase: Phase 1, Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• JS212 Combination Therapies in Metastatic Colorectal Cancer
  NCT07503756 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Capecitabine for Metastatic Colorectal Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.